The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Oncology and Biomarkers
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Oncology and Biomarkers.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Oncology and Biomarkers.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Oncology and Biomarkers are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
20. International Conference on Oncology and Biomarkers has teamed up with the Special Journal Issue on
Oncology and Biomarkers.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
When Scientific Laws and Findings Encounter Life: A Traditional Chinese Medicine Perspective
Eric Y. Zhang, L. Acu
-
The Physiological Impacts of Genital Weightlifting Conditioning: Exploring Iron Crotch Practice for Enhanced Sexual Function, Premature Ejaculation, Penile Dysfunction, Impotence, Hormonal Balance, and Prostate Health
C. Ardil
-
The Social Dynamics of Pandemics: A Clinical Sociological Analysis of Precautions and Risks
C. Ardil
-
Compressed Sensing of Fetal Electrocardiogram Signals Based on Joint Block Multi-Orthogonal Least Squares Algorithm
Xiang Jianhong, Wang Cong, Wang Linyu
-
Nano-Bioremediation of Contaminated Industrial Wastewater Using Biosynthesized AgNPs and Their Nano-Composite
Osama M. Darwesh, Sahar H. Hassan, Abd El-Raheem R. El-Shanshoury, Shawky Z. Sabae
-
Atherosclerosis Prevalence within Populations of the Southeastern United States
Samuel P. Prahlow, Anthony Sciuva, Katherine Bombly, Emily Wilson, Shiv Dhiman, Savita Arya
-
Verifying the Supremacy of Volume Modulated Arc Therapy Over Intensity Modulated Radiation Therapy: Pelvis Malignancies’ Perspective
M. Umar Farooq, T. Ahmad Afridi, M. Zia-Ul-Islam Arsalan, U. Hussain Haider, S. Ullah
-
Efficient Pre-Processing of Single-Cell Assay for Transposase Accessible Chromatin with High-Throughput Sequencing Data
Fan Gao, Lior Pachter
-
Modified Genome-Scale Metabolic Model of Escherichia coli by Adding Hyaluronic Acid Biosynthesis-Related Enzymes (GLMU2 and HYAD) from Pasteurella multocida
P. Pasomboon, P. Chumnanpuen, T. E-kobon
-
The Impact of COVID-19 Pandemic on Acute Urology Admissions in a Busy District General Hospital in the UK
D. Bheenick, M. Young, M. Elmussareh, A. Ali
-
Robotic Assistance in Nursing Care: Survey on Challenges and Scenarios
Pascal Gliesche, Kathrin Seibert, Christian Kowalski, Dominik Domhoff, Max Pfingsthorn, Karin Wolf-Ostermann, Andreas Hein
-
A Continuous Real-Time Analytic for Predicting Instability in Acute Care Rapid Response Team Activations
Ashwin Belle, Bryce Benson, Mark Salamango, Fadi Islim, Rodney Daniels, Kevin Ward
-
Survey of Epidemiology and Mechanisms of Badminton Injury Using Medical Check-Up and Questionnaire of School Age Badminton Players
Xiao Zhou, Kazuhiro Imai, Xiaoxuan Liu
-
Ozone Therapy and Pulsed Electromagnetic Fields Interplay in Controlling Tumor Growth, Symptom and Pain Management: A Case Report
J. F. Pollo Gaspary, F. Peron Gaspary, E. M. Simão, R. Concatto Beltrame, G. Orengo de Oliveira, M. S. Ristow Ferreira, F. Sartori Thies, I. F. Minello, F. dos Santos de Oliveira
-
Transcriptomics Analysis on Comparing Non-Small Cell Lung Cancer versus Normal Lung, and Early Stage Compared versus Late-Stages of Non-Small Cell Lung Cancer
Achitphol Chookaew, Paramee Thongsukhsai, Patamarerk Engsontia, Narongwit Nakwan, Pritsana Raugrut
Conference venue information will be released soon.
Anticancer Drugs
Basic Cancer and Clinical Cancer Research
Bioinformatics
Biology of cancer
Biomarker Development
Biotechnology
Cancer biomarkers
Cancer clinical trials
Cancer research
Cancer Research Tools
Diagnostic Tools
Drug Development
Epidemiology
Family Medicine
From Biomarker Discovery to Novel Therapies
Gastroenterology
Genetics of Cancer
Gynaecology
Head and Neck Cancers
Hematology
Immunology
Life Technologies
Lung Cancers
Medicine
Melanomas
Molecular Diagnostics
Neuro-Oncology
Oncology and BioMarkers
Pathology
Precision Medicine
Radiotherapy
Reagents
Skin Cancers
Soft Tissue Sarcomas
Surgical Oncology
Tumor Markers
Urology
Abstracts/Full-Text Paper Submission Deadline |
|
February 13, 2025 |
Notification of Acceptance/Rejection |
|
February 27, 2025 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
June 21, 2026 |
Conference Dates |
|
July 22-23, 2026 |